Primary Adrenal Insufficiency during Immune Checkpoint Inhibitor Treatment: Case Reports and Review of the Literature

被引:15
|
作者
Salinas, Carlos [1 ]
Renner, Alex [1 ]
Rojas, Carlos [1 ,2 ]
Samtani, Suraj [1 ]
Burotto, Mauricio [1 ,2 ]
机构
[1] Med Oncol Serv Bradford Hill, Santiago, Chile
[2] Clin Univ Andes, Med Oncol Serv, Las Condes, Chile
来源
CASE REPORTS IN ONCOLOGY | 2020年 / 13卷 / 02期
关键词
Ipilimumab; Nivolumab; Primary adrenal insufficiency; Immune-related adverse events; NIVOLUMAB PLUS IPILIMUMAB; OPEN-LABEL; MULTICENTER;
D O I
10.1159/000507652
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
As the indications and clinical use of immune checkpoint inhibitors increase, it is expected that we will face some of their less frequently reported complications. Primary adrenal insufficiency is one of them, and given its unspecific symptoms and potentially serious consequences, it is important to have a high degree of clinical suspicion. We present 3 cases and a review of the literature concerning its main clinical characteristics, diagnostics, and management.
引用
收藏
页码:621 / 626
页数:6
相关论文
共 50 条
  • [21] Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Neurologic Toxicity: Illustrative Case and Review of the Literature
    Reynolds, Kerry L.
    Guidon, Amanda C.
    ONCOLOGIST, 2019, 24 (04) : 435 - 443
  • [22] Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature
    Feifei Wang
    Yang Liu
    Wei Xu
    Changjing Zhang
    Jianhong Lv
    Shaolin Ma
    Journal of Medical Case Reports, 15
  • [23] Primary Adrenal Lymphoma as a Rare Cause of Primary Adrenal Insufficiency: Challenges in Management and a Review of the Literature
    Somasundaram, Hannah
    Boyer, Pierre-Nicolas
    Casey, John
    Wong, Mimi
    Shenoy, Vasant
    AACE CLINICAL CASE REPORTS, 2022, 8 (05): : 199 - 203
  • [24] Immune checkpoint inhibitor-related chronic pneumonitis: a case report and literature review
    Wang, Yuan-Di
    Yuan, Shengfang
    Wen, Cuiling
    Ji, Zexuan
    Xiang, Baoli
    Wang, Bu
    Zhang, Zhihua
    IMMUNOTHERAPY, 2023, 15 (14) : 1117 - 1123
  • [25] Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature
    Wang, Feifei
    Liu, Yang
    Xu, Wei
    Zhang, Changjing
    Lv, Jianhong
    Ma, Shaolin
    JOURNAL OF MEDICAL CASE REPORTS, 2021, 15 (01)
  • [26] Primary adrenal insufficiency induced by immune checkpoint inhibitors: biological, clinical, and radiological aspects
    Martella, Serafina
    Lucas, Minke
    Porcu, Michele
    Perra, Laura
    Denaro, Nerina
    Pretta, Andrea
    Deias, Giulia
    Willard-Gallo, Karen
    Parra, Hector Soto
    Saba, Luca
    Scartozzi, Mario
    Wekking, Demi
    Kok, Marleen
    Aiello, Marco Maria
    Solinas, Cinzia
    SEMINARS IN ONCOLOGY, 2023, 50 (06) : 144 - 148
  • [27] Airway disorders associated with immune checkpoint inhibitor therapy: Two case reports and a systematic review
    Kawakami, Naoki
    Saito, Hiroaki
    Takahashi, Susumu
    Kajie, Shinpei
    Kato, Rina
    Shimaya, Kazuhiro
    Wakai, Yoko
    Saito, Kazuhito
    Sakashita, Mai
    SEMINARS IN ONCOLOGY, 2022, 49 (06) : 439 - 455
  • [28] Immune checkpoint inhibitor myocarditis in thymic epithelial tumors: a case report and literature review
    Feng, Ye
    Zheng, Peng
    Zhang, Wei
    Yang, Sheng
    You, Yundan
    Chen, Yong
    Ye, Yong
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (02) : 1208 - 1218
  • [29] Immune checkpoint inhibitor use and tuberculosis: a systematic review of the literature
    Zaemes, Jacob
    Kim, Chul
    EUROPEAN JOURNAL OF CANCER, 2020, 132 : 168 - 175
  • [30] Encephalitis in a Patient With Melanoma Treated With Immune Checkpoint Inhibitors: Case Presentation and Review of the Literature
    Gkoufa, Aikaterini
    Gogas, Helen
    Diamantopoulos, Panagiotis T.
    Ziogas, Dimitrios C.
    Psichogiou, Mina
    JOURNAL OF IMMUNOTHERAPY, 2020, 43 (07) : 224 - 229